BeyondSpring (BYSI) Total Current Liabilities (2015 - 2026)
BeyondSpring's (BYSI) quarterly Total Current Liabilities came in at $14.2 million in Q2 2026, up 21.0% year-over-year from $11.7 million in Q2 2025, and up 14.74% quarter-over-quarter from $12.4 million in Q1 2026.
Analysis
BeyondSpring (BYSI) Total Current Liabilities (2015 - 2026) Analysis & Trends
BeyondSpring has disclosed Total Current Liabilities across 12 years of filings, most recently posting $14.2 million for Q2 2026.
- In Q2 2026, Total Current Liabilities rose 21.0% year-over-year to $14.2 million; the TTM figure through Jun 2026 stood at $14.2 million (up 21.0% YoY), while the FY2025 annual figure was $13.6 million, up 23.31% from the prior year.
- Total Current Liabilities came in at $14.2 million for Q2 2026 at BeyondSpring, up from $12.4 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $14.2 million in Q2 2026 to a low of $6.8 million in Q2 2023.
- Average Total Current Liabilities over 5 years is $10.8 million, with a median of $11.4 million recorded in 2022.
- Year-over-year, Total Current Liabilities slumped 51.49% in 2022 and soared 43.28% in 2025.
- Over 5 years, Total Current Liabilities stood at $7.4 million in 2022, then climbed by 8.24% to $8.0 million in 2023, then surged by 38.35% to $11.0 million in 2024, then gained by 23.31% to $13.6 million in 2025, then gained by 4.54% to $14.2 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $14.2 million in Q2 2026, $12.4 million in Q1 2026, and $13.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 54.90 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 41.64 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 27.73 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 31.75 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 32.65 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 37.11 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 354.06 Mn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 1.31 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 607.80 Mn |
| 10 | BeyondSpring | 31.51 Mn | 31.51 Mn | - | 14.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.19 Mn |
| Mar 31, 2026 | 12.37 Mn |
| Dec 31, 2025 | 13.58 Mn |
| Sep 30, 2025 | 12.89 Mn |
| Jun 30, 2025 | 11.73 Mn |
| Mar 31, 2025 | 12.67 Mn |
| Dec 31, 2024 | 11.01 Mn |
| Jun 30, 2024 | 8.19 Mn |
| Dec 31, 2023 | 7.96 Mn |
| Jun 30, 2023 | 6.82 Mn |
| Dec 31, 2022 | 7.35 Mn |
| Jun 30, 2022 | 11.11 Mn |
| Dec 31, 2021 | 15.16 Mn |
| Sep 30, 2021 | 18.56 Mn |
| Jun 30, 2021 | 16.57 Mn |
| Mar 31, 2021 | 12.63 Mn |
| Dec 31, 2020 | 13.77 Mn |
| Sep 30, 2020 | 12.82 Mn |
| Jun 30, 2020 | 11.31 Mn |
| Mar 31, 2020 | 12.21 Mn |